Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Carboplatin, and what generic Carboplatin alternatives are available?

Carboplatin is a drug marketed by Pliva, Mylan Labs Ltd, Hospira, Gland Pharma Ltd, Sun Pharma Global, Pliva Lachema, Actavis Totowa, Fresenius Kabi Oncol, Fresenius Kabi Usa, Teva Pharms Usa, West-ward Pharms Int, Sandoz, Cipla Ltd, Watson Labs, Akorn, Pharmachemie Bv, Accord Hlthcare, Sandoz Inc, Ingenus Pharms Llc, Sanja Pharms Co, Teva Parenteral, Nanjing King-friend, and Mylan Institutional. and is included in thirty-three NDAs.

The generic ingredient in CARBOPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the carboplatin profile page.

Summary for Tradename: CARBOPLATIN

Suppliers / Packagers: see list10
Bulk Api Vendors: see list73
Clinical Trials: see list770
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CARBOPLATIN at DailyMed

Pharmacology for Tradename: CARBOPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
INJECTABLE;IV (INFUSION)206775-004Feb 9, 2017APRXNoNo► Subscribe► Subscribe
Mylan Institutional
INJECTABLE;IV (INFUSION)077998-002Apr 24, 2007APRXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
INJECTABLE;IV (INFUSION)077247-003Oct 21, 2004APRXNoNo► Subscribe► Subscribe
Teva Pharms Usa
INJECTABLE;IV (INFUSION)077139-002Sep 21, 2005APRXNoYes► Subscribe► Subscribe
Ingenus Pharms Llc
INJECTABLE;IV (INFUSION)208487-001Apr 26, 2017APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus